Impact of Point-of-Care EID for HIV-Exposed Infants

NACompletedINTERVENTIONAL
Enrollment

9,539

Participants

Timeline

Start Date

August 1, 2017

Primary Completion Date

October 30, 2019

Study Completion Date

October 31, 2019

Conditions
HIV/AIDSInfant MorbidityPediatric HIV InfectionTransmission, Perinatal Infection
Interventions
DIAGNOSTIC_TEST

Point of Care Early Infant Diagnosis

HIV testing where the blood sample is processed at either the facility itself or a nearby site that is closer to the facility than a laboratory. With POC EID, blood samples do not have to travel to the laboratory for processing.

DIAGNOSTIC_TEST

Standard of Care Early Infant Diagnosis

Conventional laboratory based EID testing

Trial Locations (2)

Unknown

Elizabeth Glaser Pediatric AIDS Foundation, Nairobi

Elizabeth Glaser Pediatric AIDS Foundation, Harare

All Listed Sponsors
collaborator

UNITAID

OTHER

lead

Elizabeth Glaser Pediatric AIDS Foundation

OTHER

NCT03824067 - Impact of Point-of-Care EID for HIV-Exposed Infants | Biotech Hunter | Biotech Hunter